Laminin-111 derived peptides AG73 and C16 regulate invadopodia activity of a human adenoid cystic carcinoma cell line

Experimental Cell Research

Volumn 317, Issue 18, 2011, Pages 2562-2572

  Nascimento, Camila F ^a   de Siqueira, Adriane S ^a   Pinheiro, João J V ^a,b   Freitas, Vanessa M ^a,c   Jaeger, Ruy G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c UFABC   (Brazil)

Author keywords

Adenoid cystic carcinoma; ERK 1 2; Integrins; Invadopodia; Laminin; Rac

Indexed keywords

BETA1 INTEGRIN; LAMININ; LAMININ 111; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE; PEPTIDE AG73; PEPTIDE C16; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INVADOPODIUM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 80053572552     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.08.022     Document Type: Article

References (59)

1. Barnes L., Eveson J.W., Reichart P., S.D. Pathology and Genetics of Head and Neck Tumours (WHO Classification of Tumours) 2005, IARC Press, Lyon.
2. Seifert G., Sobin L.H. The World Health Organization's histological classification of salivary gland tumors. A commentary on the second edition. Cancer 1992, 70:379-385.
3. Dardick I. Color Atlas/Text Of Salivary Gland Tumor Pathology 1996, Igaku-Shoin, New York.
4. Wegner A., Wasniewska E., Jarmolowska-Jurczyszyn D., Golusinski W., Biczysko W. The role of immunohistochemical staining (protein p53, cyclin D1) in the prognosis of adenoid cystic carcinoma salivary gland tumors. Otolaryngol Pol. 2007, 61:423-427.
5. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2:563-572.
6. Ekblom P. Receptors for laminins during epithelial morphogenesis. Curr. Opin. Cell. Biol. 1996, 8:700-706.
7. Wernert N. The multiple roles of tumour stroma. Virchows Arch. 1997, 430:433-443.
8. Yurchenco P.D., Amenta P.S., Patton B.L. Basement membrane assembly, stability and activities observed through a developmental lens. Matrix Biol. 2004, 22:521-538.
9. Aumailley M., Bruckner-Tuderman L., Carter W.G., Deutzmann R., Edgar D., Ekblom P., Engel J., Engvall E., Hohenester E., Jones J.C., Kleinman H.K., Marinkovich M.P., Martin G.R., Mayer U., Meneguzzi G., Miner J.H., Miyazaki K., Patarroyo M., Paulsson M., Quaranta V., Sanes J.R., Sasaki T., Sekiguchi K., Sorokin L.M., Talts J.F., Tryggvason K., Uitto J., Virtanen I., von der Mark K., Wewer U.M., Yamada Y., Yurchenco P.D. A simplified laminin nomenclature. Matrix Biol. 2005, 24:326-332.
10. Kleinman H.K., Philp D., Hoffman M.P. Role of the extracellular matrix in morphogenesis. Curr. Opin. Biotechnol. 2003, 14:526-532.
11. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat. Rev. Cancer 2004, 4:448-456.
12. Faisal Khan K.M., Laurie G.W., McCaffrey T.A., Falcone D.J. Exposure of cryptic domains in the alpha 1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression. J. Biol. Chem. 2002, 277:13778-13786.
13. Mott J.D., Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell. Biol. 2004, 16:558-564.
14. Schenk S., Quaranta V. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell. Biol. 2003, 13:366-375.
15. Davis G.E., Bayless K.J., Davis M.J., Meininger G.A. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am. J. Pathol. 2000, 156:1489-1498.
16. Engbring J.A., Hoffman M.P., Karmand A.J., Kleinman H.K. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan. Cancer Res. 2002, 62:3549-3554.
17. Freitas V.M., Vilas-Boas V.F., Pimenta D.C., Loureiro V., Juliano M.A., Carvalho M.R., Pinheiro J.J., Camargo A.C., Moriscot A.S., Hoffman M.P., Jaeger R.G. SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway. Am. J. Pathol. 2007, 171:124-138.
18. Gama-de-Souza L.N., Cyreno-Oliveira E., Freitas V.M., Melo E.S., Vilas-Boas V.F., Moriscot A.S., Jaeger R.G. Adhesion and protease activity in cell lines from human salivary gland tumors are regulated by the laminin-derived peptide AG73, syndecan-1 and beta1 integrin. Matrix Biol. 2008, 27:402-419.
19. Grant D.S., Zukowska Z. Revascularization of ischemic tissues with SIKVAV and neuropeptide Y (NPY). Adv. Exp. Med. Biol. 2000, 476:139-154.
20. Hoffman M.P., Nomizu M., Roque E., Lee S., Jung D.W., Yamada Y., Kleinman H.K. Laminin-1 and laminin-2G-domain synthetic peptides bind syndecan-1 and are involved in acinar formation of a human submandibular gland cell line. J. Biol. Chem. 1998, 273:28633-28641.
21. Iwamoto Y., Nomizu M., Yamada Y., Ito Y., Tanaka K., Sugioka Y. Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR). Br. J. Cancer 1996, 73:589-595.
22. Nomizu M. How many active sites are located on laminin molecule?. Tanpakushitsu Kakusan Koso 2000, 45:2475-2482.
23. Song S.Y., Nomizu M., Yamada Y., Kleinman H.K. Liver metastasis formation by laminin-1 peptide (LQVQLSIR)-adhesion selected B16-F10 melanoma cells. Int. J. Cancer 1997, 71:436-441.
24. Siqueira A.S., Gama-de-Souza L.N., Arnaud M., Pinheiro J.J., Jaeger R.G. Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin. Tumour Biol. 2010, 31:46-58.
25. Alexander N.R., Branch K.M., Parekh A., Clark E.S., Iwueke I.C., Guelcher S.A., Weaver A.M. Extracellular matrix rigidity promotes invadopodia activity. Curr. Biol. 2008, 18:1295-1299.
26. Artym V.V., Zhang Y., Seillier-Moiseiwitsch F., Yamada K.M., Mueller S.C. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 2006, 66:3034-3043.
27. Buccione R., Orth J.D., McNiven M.A. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell. Biol. 2004, 5:647-657.
28. Desai B., Ma T., Chellaiah M.A. Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion. J. Biol. Chem. 2008, 283:13856-13866.
29. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell. Biol. 2007, 17:107-117.
30. McNiven M.A., Baldassarre M., Buccione R. The role of dynamin in the assembly and function of podosomes and invadopodia. Front. Biosci. 2004, 9:1944-1953.
31. Weaver A.M. Invadopodia. Curr. Biol. 2008, 18:R362-R364.
32. Clark E.S., Whigham A.S., Yarbrough W.G., Weaver A.M. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 2007, 67:4227-4235.
33. Seals D.F., Azucena E.F., Pass I., Tesfay L., Gordon R., Woodrow M., Resau J.H., Courtneidge S.A. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell. 2005, 7:155-165.
34. Nascimento C.F., Gama-De-Souza L.N., Freitas V.M., Jaeger R.G. Role of MMP9 on invadopodia formation in cells from adenoid cystic carcinoma. Study by laser scanning confocal microscopy. Microsc. Res. Tech. 2010, 73:99-108.
35. Freitas V.M., Jaeger R.G. The effect of laminin and its peptide SIKVAV on a human salivary gland adenoid cystic carcinoma cell line. Virchows Arch. 2002, 441:569-576.
36. Freitas V.M., Scheremeta B., Hoffman M.P., Jaeger R.G. Laminin-1 and SIKVAV a laminin-1-derived peptide, regulate the morphology and protease activity of a human salivary gland adenoid cystic carcinoma cell line. Oral Oncol 2004, 40:483-489.
37. Ponce M.L., Nomizu M., Kleinman H.K. An angiogenic laminin site and its antagonist bind through the alpha(v)beta3 and alpha5beta1 integrins. FASEB J. 2001, 15:1389-1397.
38. Dodd R.L., Slevin N.J. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncology 2006, 42:759-769.
39. Fordice J., Kershaw C., El-Naggar A., Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch. Otolaryngology-Head Neck Surg. 1999, 125:149-152.
40. Ramer N., Wu H., Sabo E., Ramer Y., Emanuel P., Orta L., Burstein D.E. Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. Cancer 2010, 116:77-83.
41. Greer R.O., Said S., Shroyer K.R., Marileila V.G., Weed S.A. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Oral Oncol. 2007, 43:735-741.
42. Dedes K.J., Lopez-Garcia M.A., Geyer F.C., Lambros M.B., Savage K., Vatcheva R., Wilkerson P., Wetterskog D., Lacroix-Triki M., Natrajan R., Reis-Filho J.S. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast Cancer Res. Treat. 2010, 124:653-666.
43. Timpson P., Wilson A.S., Lehrbach G.M., Sutherland R.L., Musgrove E.A., Daly R.J. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. Cancer Res. 2007, 67:9304-9314.
44. Yamada S., Yanamoto S., Kawasaki G., Mizuno A., Nemoto T.K. Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma. Pathol. Oncol. Res. 2010, 16:523-531.
45. Kayano K., Shimada T., Shinomiya T., Nakai S., Hisa Y., Aoki T., Seiki M., Okada Y. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. J. Pathol. 2004, 202:403-411.
46. Atkinson J.M., Pennington C.J., Martin S.W., Anikin V.A., Mearns A.J., Loadman P.M., Edwards D.R., Gill J.H. Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: correlation of MMP-14 mRNA expression and proteolytic activity. Eur. J. Cancer 2007, 43:1764-1771.
47. Karadag N., Kirimlioglu H., Isik B., Yilmaz S., Kirimlioglu V. Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis. Appl. Immunohistochem. Mol. Morphol. 2008, 16:148-152.
48. Comoglio P.M., Trusolino L. Cancer: the matrix is now in control. Nat. Med. 2005, 11:1156-1159.
49. Tunggal L., Ravaux J., Pesch M., Smola H., Krieg T., Gaill F., Sasaki T., Timpl R., Mauch C., Aumailley M. Defective laminin 5 processing in cylindroma cells. Am. J. Pathol. 2002, 160:459-468.
50. Kuratomi Y., Nomizu M., Nielsen P.K., Tanaka K., Song S.Y., Kleinman H.K., Yamada Y. Identification of metastasis-promoting sequences in the mouse laminin alpha 1 chain. Exp. Cell. Res. 1999, 249:386-395.
51. Kuratomi Y., Nomizu M., Tanaka K., Ponce M.L., Komiyama S., Kleinman H.K., Yamada Y. Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells. Br. J. Cancer 2002, 86:1169-1173.
52. Patarroyo M., Tryggvason K., Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin. Cancer Biol. 2002, 12:197-207.
53. Mueller S.C., Ghersi G., Akiyama S.K., Sang Q.X., Howard L., Pineiro-Sanchez M., Nakahara H., Yeh Y., Chen W.T. A novel protease-docking function of integrin at invadopodia. J. Biol. Chem. 1999, 274:24947-24952.
54. Deryugina E.I., Ratnikov B., Monosov E., Postnova T.I., DiScipio R., Smith J.W., Strongin A.Y. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell. Res. 2001, 263:209-223.
55. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514.
56. Takai Y., Sasaki T., Tanaka K., Nakanishi H. Rho as a regulator of the cytoskeleton. Trends Biochem. Sci. 1995, 20:227-231.
57. Keely P.J., Westwick J.K., Whitehead I.P., Der C.J., Parise L.V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997, 390:632-636.
58. Nakahara H., Otani T., Sasaki T., Miura Y., Takai Y., Kogo M. Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells. Genes Cells 2003, 8:1019-1027.
59. Morgan M.R., Thomas G.J., Russell A., Hart I.R., Marshall J.F. The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9. J. Biol. Chem. 2004, 279:26533-26539.